Pharma companies fined over $80 billion for consumer-related violations

Total Penalties in USD (Billions) for All Companies: 2010-2023 H1
Limited by consumer offense types: Drug or medical equipment safety violation, Off-label or unapproved promotion of medical products, False Claims Act and related, Price-fixing or anti-competitive practices, Fraud, Product safety violation, Controlled Substances Act violation
Source: Violation Tracker